Oraz Pharma Private Limited
About Oraz Pharma Private Limited
Data last updated:
Oraz Pharma Private Limited is a private limited company based in Bahraich, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 01 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24100UP2010PTC040832. Its GSTIN is 09AABCO3161E1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Rabia Usmani (Managing Director) and Obaid Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 159 Shakhaiyyapura, Bahraich, Uttar Pradesh, India – 271801.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.95 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹15,271 (net margin 0.4%) and EBITDA of ₹15,356 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address159 Shakhaiyyapura, Bahraich, Uttar Pradesh, India – 271801
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Oraz Pharma Private Limited
The main business activity of Oraz Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Oraz Pharma Private Limited FY 2025 filings available
Oraz Pharma Private Limited reported revenue of ₹41.95 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Oraz Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 3% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oraz Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15,356 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15,271 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oraz Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oraz Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Oraz Pharma Private Limited
Oraz Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allonsy Ventures Private Limited | ₹41.97 Lakh (FY 2025) | •••• | •••• | 77.0% | •••• | Chennai, Tamil Nadu, India |
| Anne Medicare Private Limited | ₹41.96 Lakh (FY 2019) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| SRBM Lifecare Private Limited | ₹41.96 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Gopalganj, Bihar, India |
| Miyara Agro-Care Private Limited | ₹41.96 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Gondia, Maharashtra, India |
| Levator Life Sciences Private Limited | ₹41.95 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Lucknow, Uttar Pradesh, India |
| Oraz Pharma Private Limited this company | ₹41.95 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Bahraich, Uttar Pradesh, India |
| Rudiment Life Science Pharmaceutical Private Limited | ₹41.95 Lakh (FY 2019) | •••• | •••• | 7.0% | •••• | Bhopal, Madhya Pradesh, India |
| Oxytech Engineers Private Limited | ₹41.95 Lakh (FY 2025) | •••• | •••• | 9431.0% | •••• | Faridabad, Haryana, India |
| Microsap India Private Limited | ₹41.94 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Schweissen Metal Industries Private Limited | ₹41.94 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Jamnagar, Gujarat, India |
| Phiesi International Private Limited | ₹41.93 Lakh (FY 2024) | •••• | •••• | •••• | Gurgaon, Haryana, India |
Peers are the five companies nearest above and the five nearest below Oraz Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Oraz Pharma Private Limited
Oraz Pharma Private Limited is audited by D MALIK & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D MALIK & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Oraz Pharma Private Limited
Oraz Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rabia Usmani | Managing Director | 01 Jun 2010 | 16 Years 4 Months | Current |
| Obaid Ahmad | Director | 01 Jun 2010 | 16 Years 4 Months | Current |
Ownership and Shareholding of Oraz Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oraz Pharma Private Limited
Oraz Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Oraz Pharma Private Limited
Employment history and EPFO contributions of people linked to Oraz Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oraz Pharma Private Limited
Oraz Pharma Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Obaid Ahmad was appointed as Director on 01 Jun 2010.
Credit Ratings, Litigation & Regulatory Alerts for Oraz Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oraz Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oraz Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oraz Pharma Private Limited
Oraz Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCO3161E1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oraz Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oraz Pharma Private Limited
Oraz Pharma is an active private limited company based in Bahraich, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 01 June 2010 (16+ years old) and is registered under CIN U24100UP2010PTC040832.
Oraz Pharma reported revenue of ₹41.95 Lakh for FY 2025 (down 3% YoY).
Oraz Pharma has 2 current directors:
- Rabia Usmani - Managing Director
- Obaid Ahmad - Director
Oraz Pharma reported a net profit of ₹15,271 (net margin 0.4%) and EBITDA of ₹15,356 (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oraz Pharma is -4% over three years and -4% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Oraz Pharma is 09AABCO3161E1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Oraz Pharma is U24100UP2010PTC040832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oraz Pharma was incorporated on 01 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Oraz Pharma by revenue are Allonsy Ventures Private Limited, Anne Medicare Private Limited, SRBM Lifecare Private Limited, Miyara Agro-Care Private Limited, Levator Life Sciences Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Obaid Ahmad was appointed as Director on 01 Jun 2010. Rabia Usmani was appointed as Managing Director on 01 Jun 2010.
The registered office of Oraz Pharma is at 159 Shakhaiyyapura, Bahraich, Uttar Pradesh, India – 271801.